Cell type-specific microRNA therapies for myocardial infarction.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33568517.
- Also identified by DOI 10.1126/scitranslmed.abd0914 and PMC identifier 8848299.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Current interventions fail to recover injured myocardium after infarction and prompt the need for development of cardioprotective strategies. Of increasing interest is the therapeutic use of microRNAs to control gene expression through specific targeting of mRNAs. In this Review, we discuss current microRNA-based therapeutic strategies, describing the outcomes and limitations of key microRNAs with a focus on target cell types and molecular pathways. Last, we offer a perspective on the outlook of microRNA therapies for myocardial infarction, highlighting the outstanding challenges and emerging strategies.
Medical subject headings
- MicroRNAs
- Myocardial Infarction